![Avidity Biosciences, Inc. logo](/logos/RNA.webp)
Avidity Biosciences, Inc.
NASDAQ:RNA
Overview | Financials
Company Name | Avidity Biosciences, Inc. |
Symbol | RNA |
Currency | USD |
Price | 40.46 |
Market Cap | 4,738,715,660 |
Dividend Yield | 0% |
52-week-range | 4.825 - 48.801 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Sarah Boyce |
Website | https://www.aviditybiosciences.com |
An error occurred while fetching data.
About Avidity Biosciences, Inc.
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD